Vertex Exec Charles Wagner Executes Dual Buy‑Sell Hedge, Signaling Long‑Term Confidence at Vertex Pharmaceuticals <|constrain|>2026 <|end|>
Vertex insider trade: Charles Wagner’s 10‑b5‑1 buy‑sell reveals confidence in Vertex’s growth and a strategic, rule‑based approach that could boost the stock’s momentum.
4 minutes to read